Clinical Trial Update: Psoriatic Disease and Related Manifestations; Real World Evidence in Brazilian Secukinumab Environment

View source ↗

Summary

A completed real-world evidence study evaluating secukinumab (Cosentyx) in Brazilian patients with psoriasis and psoriatic arthritis. The study analyzes outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis (PsO), Psoriatic Arthritis (PsA) | Status: COMPLETED